| P2RY1 |
P2RY1: P2Y purinoceptor 1 |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
0.443 |
Evidence |
|
| PTGER3 |
PTGER3: Prostaglandin E2 receptor EP3 subtype |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.443 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
DOK4 |
DOK4: Docking protein 4 |
0.443 |
Evidence |
|
| SMCX |
JARID1C, DXS1272E, SMCX, XE169: Histone demethylase JARID1C |
MAFB |
MAFB, KRML: Transcription factor MafB |
0.443 |
Evidence |
|
| LTBR |
LTBR, D12S370, TNFCR, TNFRSF3: Tumor necrosis factor receptor superfamily member |
TNFRSF4 |
TNFRSF4, TXGP1L: Tumor necrosis factor receptor superfamily member 4 precursor |
0.443 |
Evidence |
|
| CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
OR1D2 |
OR1D2, OLFR1: Olfactory receptor 1D2 |
0.443 |
Evidence |
|
| CCR1 |
CCR1, CMKBR1, CMKR1, SCYAR1: C-C chemokine receptor type 1 |
CCR4 |
CCR4, CMKBR4: C-C chemokine receptor type 4 |
0.443 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
0.443 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
GRB14 |
GRB14: Growth factor receptor-bound protein 14 |
0.443 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
HUNK |
HUNK, MAKV: Hormonally up-regulated neu tumor-associated kinase |
0.443 |
Evidence |
|
| TNFRSF7 |
CD27, TNFRSF7: CD27 antigen precursor |
LTBR |
LTBR, D12S370, TNFCR, TNFRSF3: Tumor necrosis factor receptor superfamily member |
0.443 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.443 |
Evidence |
|
| LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
0.443 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
0.443 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
0.443 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.443 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
GPR1 |
GPR1: Probable G-protein coupled receptor 1 |
0.443 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
OR1D2 |
OR1D2, OLFR1: Olfactory receptor 1D2 |
0.443 |
Evidence |
|
| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
GPR132 |
GPR132, G2A: Probable G-protein coupled receptor 132 |
0.443 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
KHDRBS3 |
KHDRBS3, SALP, SLM2: KH domain-containing, RNA-binding, signal transduction-asso |
0.443 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
P2RY14 |
P2RY14, GPR105, KIAA0001: P2Y purinoceptor 14 |
0.443 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
CNR2 |
CNR2: Cannabinoid receptor 2 |
0.443 |
Evidence |
|
| KRT1 |
KRT1, KRTA: Keratin, type II cytoskeletal 1 |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
0.443 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
MYF6 |
MYF6: Myogenic factor 6 |
0.443 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
0.443 |
Evidence |
|